Diabetes care devices are used in the treatment and management of diabetes. Insulin delivery devices are used to inject measured doses of insulin through the skin and into the fatty tissues below. An insulin pump is an insulin delivery device that administers programmed doses of insulin for diabetes management. A blood glucose meter is an electronic diabetic management device used for measuring blood glucose levels. GlobalData uses proprietary data and analytics to provide a comprehensive report on the insulin pumps and continuous glucose monitors market in Australia. Buy the latest report here.
In 2022, GlobalData’s Market Model methodology determined that the leading player in the insulin pumps and continuous glucose monitors market in Australia was Abbott Laboratories followed by DexCom, F. Hoffmann-La Roche, Insulet, Medtronic, Tandem Diabetes Care, Ypsomed and Zealand Pharma.
Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.
The insulin pump consists of a battery run pump, an insulin reservoir and an infusion set with a tubing system for subcutaneous intervention. Traditional Insulin Pumps & Accessories and patch pumps are tracked under this segment. The Continuous glucose monitoring system includes an implantable sensor with wireless transmission capability and a monitor. The Continuous glucose monitoring system includes an implantable sensor with wireless transmission capability and a monitor.
The insulin pumps and continuous glucose monitors market in Australia can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.
For the latest analysis of the market size insulin pumps and continuous glucose monitors in Australia, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.
